Repeated dose samarium 153 lexidronam in patients with prostate cancer bone metastases.

被引：0
|
作者：
Sartor, AO
Reid, R
Higano, C
Bushnell, D
Quick, D
机构：
[1] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA
[2] London Hlth Sci Ctr, London, ON, Canada
[3] Univ Washington, Seattle, WA 98195 USA
[4] Iowa City VA Med Ctr, Iowa City, IA USA
[5] Joe Arrington Canc Ctr, Lubbock, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：411S / 411S
页数：1
相关论文
共 50 条
  • [41] Efficacy, safety and tolerability of repetitive doses of samarium-153 lexidronam (153Sm-EDTMP) in patients affected with bone methastasis from solid tumors
    Catalano, M.
    De Rimini, M. L.
    Piccolo, S.
    Borrelli, G.
    Bifulco, M.
    Magliulo, B.
    Mazzarella, G.
    Muto, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S433 - S433
  • [42] The antalgic effect of 153 Samarium in prostate cancer painful bone metastases - a 10 year experience at the University Hospital of Besan on, France
    Rusu, D.
    Rusu, V.
    Caoduro, C.
    Angoue, O.
    Ungureanu, C.
    Klingelschmitt, S.
    Boulahdour, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S305 - S305
  • [43] Effects of low-dose capecitabine on Samarium-153-EDTMP therapy for painful bone metastases
    Barai, Sukanta
    Gambhir, Sanjay
    Rastogi, Neeraj
    Mandani, Anil
    Siddegowda, Murthy
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2015, 30 (02): : 111 - 115
  • [44] A new parameter of bone scintigraphy: Relation between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
    Wakabayashi, Hiroshi
    Nakajima, Kenichi
    Mizokami, Atsushi
    Namiki, Mikio
    Inaki, Anri
    Taki, Junichi
    Kinuya, Seigo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] The Wnt/neta-catenin pathway is expressed in prostate cancer and in bone metastases.
    Chen, G
    Shukeir, N
    Potti, A
    Sircar, K
    Goltzman, D
    Rabbani, SA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S114 - S114
  • [46] Safety and Efficacy of Repeated Samarium-153-Edtmp Treatment in Patients With Painful Bone Metastasis
    Slim, I.
    Zaabar, L.
    Meddeb, I.
    Ben Sellem, D.
    Letaief, B.
    Mhiri, A.
    Ben Slimene, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S480 - S480
  • [47] The relation between bone pain response and skeletal metastases in cancer patients receiving 153Samarium-EDTMP therapy
    Elzahry, Mai
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [48] Prostatic Acid Phosphatase: A Potential Target for Treating Prostate Cancer Bone Metastases.
    Leiter, A. C.
    Kirschenbaum, A.
    Yao, S.
    Levine, A. C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 : S116 - S116
  • [49] Treatment of Painful Bone Metastases in Hormone-Refractory Prostate Cancer with Zoledronic Acid and Samarium-153-Ethylenediaminetetramethylphosphonic Acid Combined
    Lam, Marnix G. E. H.
    de Klerk, John M. H.
    Zonnenberg, Bernard A.
    JOURNAL OF PALLIATIVE MEDICINE, 2009, 12 (07) : 649 - 651
  • [50] Ibandronat-"Loading Dose" - Effects on refractory Bone pain in Patients with far advanced Breast cancer and bone Metastases.
    Sittig, H-B
    ONKOLOGIE, 2010, 33 : 196 - 196
12345